InsidersTradesSigma
Browse the complete record of transactions filed by Ciambrone William, Vice-Président Exécutif. Director active across 1 companies, notably Sarepta Therapeutics, Inc.. In total, 1 filings have been logged. The latest transaction was disclosed on 4 March 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Ciambrone William is Executive Vice President at Sarepta Therapeutics, Inc. He plays a crucial role in the strategic direction of the company, overseeing operations and contributing to innovation in the biotechnology field. His leadership is essential for achieving the company's objectives.